Why the study?
Novel noninvasive techniques are needed to advance understanding of pulmonary circulation and right ventricle hemodynamics using echocardiography.
Does percutaneous mitral balloon valvuloplasty improve pulmonary pulse transit time in patients with moderate-to-severe mitral stenosis and pulmonary hypertension?
Does percutaneous mitral balloon valvuloplasty improve pulmonary pulse transit time in patients with moderate-to-severe mitral stenosis and pulmonary hypertension?
Pulmonary pulse transit time is a valid noninvasive echocardiographic parameter for assessing hemodynamic improvement in pulmonary hypertension following balloon mitral valvuloplasty.
Answers are grounded in this paper and cite their sources.
pPTT may noninvasively track pulmonary hemodynamics after BMV; leaves open its role in PAH monitoring pending validation studies.
Background: Transthoracic echocardiography remains a crucial diagnostic tool for the identification of pulmonary arterial hypertension (PAH). We eagerly await the novel noninvasive techniques development that significantly advances our knowledge of the pulmonary circulation and right ventricle. Objective: The objective of this study was to assess pulmonary arterial hemodynamics using pulmonary pulse transit time (pPTT) following balloon mitral valvuloplasty (BMV). Patients and Methods: Thirty-three patients with moderate-to-severe mitral stenosis (MS) with varying pulmonary hypertension degree who were presented to the National Heart Institute to do percutaneous mitral balloon valvuloplasty. Participants were evaluated for their echocardiographic variables including the pPTT, and they were followed up immediately, 1 week, 1 month, and 6 months after BMV. Results: The study demonstrated a significant and progressive improvement in the right ventricular fractional area change and the tricuspid annular plane systolic excursion (TAPSE) following BMV; on the other hand, the pulmonary artery systolic pressure demonstrated a significant decrease postprocedure and during the follow-up period. On analysis, we found a significant change observed in pPTT values postprocedure ( P < 0.001). This value showed a significant reduction immediately following the procedure and the decline continued over the subsequent follow-up periods. Each of these postprocedure measurements showed a significant decrease from the baseline ( P < 0.001). Conclusion: The pPTT was high in postcapillary pulmonary hypertension (in MS patients) and reduced after correction of causative pathology; the pPTT is a valid measure to assess the improvement in PAH after BMV.
No takes yet. Share an insight, caveat, or question.
Abdallah et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: